The University of Southampton
University of Southampton Institutional Repository

Non-compliance: the Achilles' heel of anti-fracture efficacy

Non-compliance: the Achilles' heel of anti-fracture efficacy
Non-compliance: the Achilles' heel of anti-fracture efficacy
About 50% of patients fail to comply or persist with anti-osteoporosis treatment regimens within 1 year. Poor compliance is associated with higher fracture rates. Causes of poor compliance are unknown. As it is not possible to predict poor compliance, close monitoring of compliance is needed. Despite evidence supporting the anti-fracture efficacy of several pharmacological agents, approximately 50% of patients do not follow their prescribed treatment regimen and/or discontinue treatment within 1 year. Poor compliance is associated with higher fracture rates and increased morbidity, mortality and cost. However, as poor compliance, even to placebo, is associated with adverse outcomes, the higher morbidity appears to be only partly the result of lack of treatment: as yet, undefined characteristics place poor compliers at higher risk of morbidity and mortality. Only a small proportion (e.g., 6%) of the variability in compliance is explained by putative causal factors such as older age, co-morbidity or greater number of medications. Regimens with longer dosing intervals, such as weekly dosing, improve compliance, persistence and outcomes, but only modestly. As it is not possible to predict poor compliance, close monitoring of compliance should be an obligatory duty in clinical care. How this is best achieved has yet to be established, but poor persistence occurs as early as 3 months of starting treatment, indicating the need for early monitoring.
risk factors, complications, bone, research, female, bone density, review, fractures, bone density conservation agents, health, patient compliance, Australia, mortality, osteoporosis, comorbidity, humans, risk, prevention & control, etiology, therapeutic use, drug therapy
0937-941X
711-719
Seeman, E.
bda77f60-3ab2-4a4c-9429-8b6d5f55be96
Compston, J.
b64c0d0e-97dd-44c8-97ba-f756f0bc966d
Adachi, J.
89aeb1f8-9966-4630-b5c1-cd8314b20800
Brandi, M.L.
4147f967-9c22-494d-ae35-c8141161413d
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Wson-Hughes, B.
cbab650f-ecd2-40ea-a9a8-7f87c90b728e
Jonsson, B.
6971845f-f173-4620-a78f-e366a78688c4
Pols, H.
bf755ddd-1f21-462b-a6d5-87c992eacc7a
Cramer, J.A.
e458203c-811f-4b85-85ff-532840e68dc4
Seeman, E.
bda77f60-3ab2-4a4c-9429-8b6d5f55be96
Compston, J.
b64c0d0e-97dd-44c8-97ba-f756f0bc966d
Adachi, J.
89aeb1f8-9966-4630-b5c1-cd8314b20800
Brandi, M.L.
4147f967-9c22-494d-ae35-c8141161413d
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Wson-Hughes, B.
cbab650f-ecd2-40ea-a9a8-7f87c90b728e
Jonsson, B.
6971845f-f173-4620-a78f-e366a78688c4
Pols, H.
bf755ddd-1f21-462b-a6d5-87c992eacc7a
Cramer, J.A.
e458203c-811f-4b85-85ff-532840e68dc4

Seeman, E., Compston, J., Adachi, J., Brandi, M.L., Cooper, C., Wson-Hughes, B., Jonsson, B., Pols, H. and Cramer, J.A. (2007) Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporosis International, 18 (6), 711-719. (doi:10.1007/s00198-006-0294-8).

Record type: Article

Abstract

About 50% of patients fail to comply or persist with anti-osteoporosis treatment regimens within 1 year. Poor compliance is associated with higher fracture rates. Causes of poor compliance are unknown. As it is not possible to predict poor compliance, close monitoring of compliance is needed. Despite evidence supporting the anti-fracture efficacy of several pharmacological agents, approximately 50% of patients do not follow their prescribed treatment regimen and/or discontinue treatment within 1 year. Poor compliance is associated with higher fracture rates and increased morbidity, mortality and cost. However, as poor compliance, even to placebo, is associated with adverse outcomes, the higher morbidity appears to be only partly the result of lack of treatment: as yet, undefined characteristics place poor compliers at higher risk of morbidity and mortality. Only a small proportion (e.g., 6%) of the variability in compliance is explained by putative causal factors such as older age, co-morbidity or greater number of medications. Regimens with longer dosing intervals, such as weekly dosing, improve compliance, persistence and outcomes, but only modestly. As it is not possible to predict poor compliance, close monitoring of compliance should be an obligatory duty in clinical care. How this is best achieved has yet to be established, but poor persistence occurs as early as 3 months of starting treatment, indicating the need for early monitoring.

This record has no associated files available for download.

More information

Published date: 2007
Keywords: risk factors, complications, bone, research, female, bone density, review, fractures, bone density conservation agents, health, patient compliance, Australia, mortality, osteoporosis, comorbidity, humans, risk, prevention & control, etiology, therapeutic use, drug therapy

Identifiers

Local EPrints ID: 61502
URI: http://eprints.soton.ac.uk/id/eprint/61502
ISSN: 0937-941X
PURE UUID: c1c669e7-8912-4d34-a473-4d2cd568fe2c
ORCID for C. Cooper: ORCID iD orcid.org/0000-0003-3510-0709

Catalogue record

Date deposited: 09 Sep 2008
Last modified: 18 Mar 2024 02:44

Export record

Altmetrics

Contributors

Author: E. Seeman
Author: J. Compston
Author: J. Adachi
Author: M.L. Brandi
Author: C. Cooper ORCID iD
Author: B. Wson-Hughes
Author: B. Jonsson
Author: H. Pols
Author: J.A. Cramer

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×